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Abstract
Background: Reduced heart rate variability (HRV) is associated with a poor outcome in
patients with sinus rhythm (SR) or atrial fibrillation (AF).  However, cut-off points for HRV
measures differ between SR and AF. We hypothesized that a global index of 24-hour HRV
based on evaluation of scatterplot would describe HRV irrespective of cardiac rhythm.
Methods: 407 patients with ischemic heart disease (317 male, 90 female, mean age 57 ± 9 years)
were studied. 331 patients had SR and 76 patients had AF. 24-hour ECGs were recorded, and
standard HRV indices were calculated. Scatterplots was used to determine the HRV fraction
(HRVF, %). HRV measures were compared in respect to left ventricular ejection fraction (LVEF
£ 35% or > 35%).
Results: Standard HRV measures were higher in AF-patients despite the mean RR interval
was lower. In patients with LVEF £ 35%, standard HRV indices were lower in SR group, in
AF group only SDNN and RMSSD were reduced. The HRVF was comparably reduced (SR
39.3 ± 15.3%, AF 37.3 ± 17.9%). In patients with LVEF > 35%, HRVF did not differ
between SR (47.2 ± ± 10.5%) and AF (46.1 ± 12.1%). The HRVF correlated with SDNN
and SDANN (~0.85) in SR. Correlations were weaker in AF (~0.6). Standard  HRV indices
and HRVF showed similar relations with LVEF, but only in AF at the same range.
Conclusions: The HRV fraction allows for HRV evaluation irrespective of cardiac rhythm. The
index elicited a similar dependence of HRV on left ventricular function in SR and AF. (Cardiol J
2011; 18, 5: 538–545)
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Introduction
Heart rate variability (HRV) is a complex phe-
nomenon based mainly on parasympathetic control
of the heart [1–5]. Its analysis is proposed for risk
stratification in patients after myocardial infarction
(MI) and in heart failure (HF). Most predictive HRV
measures are complex and suffer from several limi-
tations, and the common indices are still in use [5–11].
Numerous indices derived from non-linear dyna-
mics have been introduced. But because physicians
are less familiar with the algorithms used, their
application in practice is limited [5, 12–14].
The presence of cardiac arrhythmias, especially
atrial fibrillation (AF), practically excludes reliable
HRV analysis [15] in an increasing proportion
(~30%) of patients with HF or left ventricular (LV)
dysfunction. The cut-off points for prognostic use
of HRV indices are not definitely established in pa-
tients with sinus rhythm, and often lie within nor-
mal limits. However, in post-MI patients and in HF
patients, different cut-off points have been suggest-
ed for SDNN (< 50, 65, 70 and 100 ms) and SDANN
(< 44, 50, 65.3, 97, 100 and 120 ms), respectively
[5]. The cut-off points are higher if AF is present [5].
At present, owing the limitations of available
methods, neither HRV measure can be used prac-
tically at the bedside [5, 11]. Thus, the search for
new HRV indices is important. The ideal index
should estimate the neural cardiac control irrespec-
tive of the presence of arrhythmias. It should also
show similar dependence of HRV on underlying
factors like age, gender, mean R-R interval, and LV
function [5, 16]. An achievement of these goals cre-
ates the basis of the present study.
We have developed a method of global HRV
evaluation, which introduces a simple and easy-to-
-understand index, namely the fraction of the den-
sity of selected areas of the return map (scatterplot,
Poincare plot) in relation to the total number of R-R
intervals differing from successive intervals by less
than 50 ms. The methodology has already been
introduced in normal individuals, patients with cer-
tain cardiac diseases and in AF [17–19].
Methods
Subjects
The study population consisted of 407 patients
with angiographically documented ischemic heart
disease (IHD) or with a remote MI. The 407 com-
prised 317 men and 90 women, mean age 57 ± 9 ye-
ars, who were consecutively referred to our ECG
laboratory. They were included if they gave in-
formed consent and the Holter ECG recording last-
ed at least 21 hours including a whole night and the
first four hours after awakening. Exclusion criteria
were: recent (< three months) acute coronary syn-
dromes (including unstable angina pectoris — CCS
class IV), 2/3o S-A or A-V block, incessant tachy-
cardia, an implanted pacemaker, any illness that re-
quired the use of beta-agonists or corticoids, or any
other illness that might limit life expectancy.
Based on the rhythm detected, they were di-
vided into two groups. The first included 331 pa-
tients with sinus rhythm (SR), and the second con-
sisted of 76 patients with chronic AF. In each group,
patients were categorized with respect to the LV
systolic function expressed as an echocardiogra-
phically determined LV ejection fraction (LVEF).
A reduction in the LV systolic function was recog-
nized if a LVEF £ 35% was found. Characteristics
of the groups are presented in Table 1. The study
conformed to the principles outlined in the Decla-
ration of Helsinki.
Standard HRV analysis
In each patient, a 24 hour ambulatory ECG re-
cording was obtained using a three-channel solid-
-state recorder. The ECG recordings were proce-
ssed with standard precision on a Medilog Excel 2
system (Oxford Instruments, Abingdon, UK). After
careful manual editing and visual corrections, stan-
dardised time-domain indices of HRV were obtained
using a commercially available software package.
These included mean R-R interval (RRI), standard
deviation of all normal R-R intervals (SDNN, ms),
standard deviation of averaged means of normal
R-R intervals over 5 min periods (SDANN, ms),
mean of averaged standard deviation of normal
R-R intervals over 5 min periods (SDNNI, ms), root
mean square of successive differences (RMSSD,
ms) and the percentage of neighbouring intervals
differing by more than 50 ms (pNN50).
Calculation of HRV fraction
Data with labelled RRI were stored in the files
and transferred to a personal computer (PC) for fur-
ther processing using an in-house software pack-
age. Scatterplots and their evaluation were obtained
using an algorithm written in MATLAB, implement-
ed on a PC. The scatterplot is a plot of a given R-R
interval (R-Ri) against the next RRI (R-Ri+1). In this
way, a graphic two-dimensional presentation of
beat-to-beat RRI changes is obtained. The scatterplot
area (from 0.2 to 1.8 s by 0.2 to 1.8 s) was divided
into 256 boxes each of 0.1 s interval (16 × 16, from
0.2–0.3, 0.3–0.4 and so on up to 1.7–1.8) [18].
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In each box, the number of paired RRI was count-
ed. In such a way, a matrix of numbers from
256 boxes was obtained and three-dimensional (3D)
graphs of density were plotted (Figs. 1, 2).
The index was calculated according to the for-
mula:
where N1 and N2 are the two highest numbers of
counts in any of the boxes, totalRR is the number
of all RRI, and RR50 is the number of RRI that dif-
fer from successive RRI by more than 50 ms [18].
Statistical analysis
Means and standard deviations were calculat-
ed for each parameter. The student t-test or Mann-
-Whitney U-test was used for comparisons as ap-
propriate (e.g. for age, RRI, HRV fraction and
LVEF, as normally distributed, and for standard
HRV indices, as not normally distributed, respec-
tively). Discrete data were compared using the
c2 test. Spearman rank correlation coefficients were
calculated among all measured HRV parameters.
Results
The means of the analyzed HRV variables are
shown in Table 2. The standard time-domain mea-
sures were statistically significantly higher in pa-
tients with AF, irrespective of the LV systolic func-
tion. Meanwhile, in the AF group, the mean R-R
interval was significantly shorter than in the SR
group, both in patients with low LVEF (764 ± 176 ms
vs 825 ± 134 ms, respectively, p < 0.05) and in
patients with preserved LVEF (802 ± 168 ms vs
868 ± 107 ms, respectively, p < 0.01).
The values of the new index, HRV fraction, did
not show any significant difference between the SR
patients and AF patients in corresponding groups
based on LVEF. In the SR group with depressed
LVEF, standard indices of global HRV (SDNN,
SDANN and SDNNI) showed significantly lower
values compared to those with preserved LVEF,
while in the AF group, only SDNN and RMSSD
were reduced significantly in patients with LVEF
£ 35%. The HRV fraction was reduced in those with
compromised LVEF irrespective of cardiac rhythm.
Similarly, the values of the HRV fraction did not dif-
fer between SR and AF patients with LVEF > 35%.
The examples of reduced and normal HRV in
patients with SR or AF are shown in Figures 1 and 2,
respectively. As shown in these figures, the shape
of the 3D view of the scatterplot of RRI of a patient
with AF was comparable to that of a patient with
SR. The HRV fraction indicated reduced HRV in
both cases, while in the AF patients, the SDNN
value was well within normal limits accepted for SR,
while pNN50 was even above the normal limit. The
only standard index reduced both in AF and SR
patients was SDANN, but it still indicated great-
er RR variation in AF, whereas the HRV fraction
was lower in this case. In Figure 2, the 3D scat-
terplots of patients with normal HRV showed
comparable RRI and HRV fraction values, while
standard indices were clearly higher in the case
of AF.
Table 1. Clinical characteristics of patients with
sinus rhythm (SR) and atrial fibrillation (AF).
Parameter\group SR group AF group
(n = 331) (n = 76)
Age (years)‡ 56 ± 10 63 ± 10
Gender (F/M) 67/264 21/55
CHD risk factors:
Hypertension 190 (57%) 44 (58%)
Hyperlipidemia 174 (53%) 46 (61%)
Diabetes 56 (17%) 14 (18%)
Smoking (current 266 (80%) 51 (78%)
or past)
Clinical status:
NYHA class > II  101 (31%)  30 (39%)
CCS class:
   I/II 208 (62%) 52 (68%)
   III 125 (38%) 24 (32%)
LVEF (%)† 43 ± 13 38 ± 13
LVEDD [mm] 57 ± 8 56 ± 8
Management (prior to
the study)‡:
After CABG/PTCA 232 (70%) 25 (33%)
Conservative 99 (30%) 51 (67%)
Medications:
Beta-blockers† 203 (61%) 31 (41%)
ACE inhibitors† 194 (59%) 58 (76%)
Ca antagonists 108 (33%) 21 (28%)
Diuretics‡ 128 (39%) 51 (67%)
Digoxin‡ 39 (12%) 48 (63%)
Antiarrhythmics& 45 (14%) 9 (12%)
Antiplatelet agents/ 271 (82%) 68 (89%)
/anticoagulants
Ca — calcium; CHD — coronary heart disease; NYHA — New York
Heart Association; CCS — Canadian Cardiovascular Society; LVEF —
left ventricular ejection fraction; LVEDD — left ventricular end-dia-
stolic diameter; CABG — coronary artery by-pass grafting; PTCA —
percutaneous transluminal coronary angioplasty; F — female;
M — male; &antiarrhythmics others than beta-blockers, digoxin and
verapamil or diltiazem; *p < 0.05; †p < 0.01; ‡p < 0.001; c2 test
and Student t-test were used as appropriate
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The HRV fraction correlated significantly with
standard time-domain HRV measures. In particu-
lar, there was a high correlation with SDNN (0.872),
SDANN (0.835) and SDNNI (0.718) in patients with
SR. However, in the presence of AF, these corre-
lations became less close, although still statistical-
ly significant. The HRV fraction correlated positive-
ly with RRI in both groups (Table 3).
The HRV dependence on LV function was ob-
served for most of the analyzed indices. However,
the HRV fraction showed a similar strength of rela-
tionship in patients with SR (Spearman R = 0.29,
p < 0.05) and with AF (Spearman R = 0.26, p < 0.05)
at the same range (Fig. 3). Meanwhile, for the
SDNN the coefficients of rank correlation were
even better, but at quite different ranges for patients
A B
A B
Figure 1. Examples of reduced heart rate variability (HRV) in patients with sinus rhythm (A) and atrial fibrillation (AF)
(B) In both cases, some features of heart rhythm are similar, i.e. mean RRI, SDANN, HRV fraction, while common
standard HRV indices differed substantially, i.e. SDNN or pNN50. Note that a reduction in HRV was even worse in an
AF patient, as indicated by lower values of SDANN and HRV fraction.
Figure 2. Examples of normal heart rate variability (HRV) in patients with preserved left ventricular ejection fraction
with sinus rhythm (A) and atrial fibrillation (AF) (B). In both cases, some features of heart rhythm are similar, i.e.
mean RRI and HRV fraction, while common standard HRV indices differed substantially, being clearly higher in
a patient with AF.
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Table 2. Means of the heart rate variability measures in the subgroups examined.
Sinus rhythm Atrial fibrillation
LVEF £ 35% LVEF > 35% LVEF £ 35% LVEF > 35%
n = 117 n = 214 n = 41 n = 35
RRI 825±134† 868±107 764±176* 802±168**
SDNN 107±33‡ 124±40 182±55*** † 212±57***
SDANN 93±35‡ 110±33 111±45* 132±49*
SDNNI 45±22‡ 51±17 144±47*** 160±41***
RMSSD 29±24 28±17 160±56*** † 184±49***
PNN50 7.1±10.9 6.2±7.4 55.0±12.4*** 59.2±8.7***
HRV fraction 39.3±15.3‡ 47.2±10.5 37.3±17.9† 46.1±12.1
Mann-Whitney U-test was used. AF vs SR: *p < 0.05, **p < 0.01, ***p < 0.001, LVEF < 35% vs LVEF > 35%: †p < 0.05, ‡p < 0.001; abbreviations —
see methods
Table 3. Correlations among standard time-domain heart rate variability (HRV) measures and HRV frac-
tion in patients with sinus rhythm and atrial fibrillation.
RRI SDNN SDANN SDNNI RMSSD PNN50 HRVF
RRI 0.404 0.319 0.502 0.404 0.413 0.482
SDNN 0.506 0.958 0.728 0.485 0.521 0.872
SDANN 0.409 0.843 0.560 0.337 0.382 0.835
SDNNI 0.536 0.825 0.550 0.756 0.763 0.718
RMSSD 0.554 0.759 0.468 0.889 0.941 0.445
PNN50 0.506 0.453 0.301 0.590 0.727 0.482
HRVF 0.571 0.590 0.591 0.528 0.486 0.523
Tables indicate Spearman rank coefficients. All coefficients with p < 0.001, except for pNN50 vs SDANN in the atrial fibrillation group (p < 0.01);
right upper panel — patients with sinus rhythm, left lower panel (italics) — patients with atrial fibrillation; abbreviations — see methods
Figure 3. Heart rate variability (HRV) dependence on left ventricular systolic function. Both figures show combined
scatterplots of HRV measures (HRV fraction and SDNN) against left ventricular ejection fraction (LVEF) in patients
with sinus rhythm (SR) and atrial fibrillation (AF). Solid and dotted lines show the logarithmic relationship in SR and
AF, respectively. Statistics: R — Spearman rank coefficient; *p < 0.05, ***p < 0.001.
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with SR and AF. Thus, for example, the patients
whose HRV fraction values were below 20% or
above 50% may have either SR or AF. On the con-
trary, there were no cases of patients with AF who
had SDNN below 80 ms, or of patients with SR with
SDNN above 240 ms. These differences were clear-
ly visible when comparing the curves of logarith-
mic fit. These curves were superimposed for HRV
fraction, while clearly separated for SDNN (Fig. 3).
Similar differences were seen for the other stan-
dard indices.
Discussion
The results of our study showed that a relative-
ly simple HRV parameter can describe global RRI
variation equally well in patients with SR and in pa-
tients with AF. Thus, an increasing number of pa-
tients with LV dysfunction or HF need no longer
be excluded from trials which evaluate the prognos-
tic value of a reduced HRV. At the same time, the
standard time-domain HRV measures showed dif-
ferent ranges of RRI variation in patients depend-
ing on cardiac rhythm, being significantly lower in
SR compared to AF. Stein et al. [20] found the cut-
off value of the SDANN index lower than 141 ms
helpful in distinguishing patients with AF at risk for
mortality and cardiac surgery for non-ischemic mi-
tral regurgitation. Clearly, the cited cut-off value
lies well within normal limits in patients with SR.
Using a more advanced technique, namely approxi-
mate entropy, allowed Yamada et al. [21] to evi-
dence an increased risk of mortality in 107 patients
with chronic AF with a reduced ventricular rate ir-
regularity. In our previous one-center prospective
study, we confirmed a prognostic value of HRV frac-
tion in patients with coronary artery disease irre-
spective of the absence or presence of SR [19].
The HRV fraction is determined after numeri-
cal processing of a scatterplot. The analysis of the
scatterplot has already been successfully used for
HRV evaluation in patients with MI and HF, as well
as to evaluate ventricular response to AF [22–26].
In an early paper by Woo et al. [22], a visual assess-
ment of scatterplots identified four different patterns,
of which the so-called ‘complex pattern’ carried high
risk for subsequent death in patients with HF.
An idea for the calculation of density of 3D scat-
terplots has also been reported. Hnatkova et al. [23]
determined the so-called ‘compactness index’,
which expressed the density of pairs of neighbour-
ing RRI. They showed that the compactness index
was a better predictor of mortality after an acute
MI than SDNN [23]. Again, only patients with SR
were included. In addition, the compactness index
showed higher values as HRV became smaller. The
HRV fraction describes the density of RRI pairs in
such a way that it gives greater values when there
is higher RR variability, thus making understand-
ing of the measurement easy.
As indicated by the regression analysis, in pa-
tients with SR the HRV fraction was highly posi-
tively correlated with SDNN and SDANN. In the
setting of AF, however, these correlations were
weaker. This is possibly because standard time-
domain measures took into account mainly the
magnitude of HRV. The new index quantifies both
the magnitude and distribution of RRI. In this case,
the HRV fraction is similar to the triangular index,
the second most commonly used index of HRV [27–
–29]. However, this index is especially suitable for
in-hospital clinical studies, with stable environment
and limited physical activity [27], since it is strong-
ly dependent on the distribution of RRI in the den-
sity histogram. Therefore, in cases with bi-modal
distribution, calculation of the triangular index may
lead to incorrect assessment of HRV from 24 hour
ECG. The bi-modal distribution of the RRI histogram
is commonly seen in healthy subjects and in patients
during out-of-hospital 24 hour ambulatory ECG re-
cordings. It is the result of day/night difference, as
well as physical and mental activity, which is usual-
ly greater in uncontrolled out-of-hospital conditions.
The HRV fraction is independent of the distribution,
because a sum is taken from the two boxes with the
highest number of counts, not necessarily lying close
to each other. Thus, a bi-modal distribution, which
may influence calculation of the triangular index,
does not affect the calculation of the HRV fraction.
The calculation of the HRV fraction takes into
account the influence of HR itself. Thus, at the same
level of HRV variability indicated by the value of
SDNN, but faster HR, HRV fraction is lower. This
feature of the HRV fraction is of special importance,
since HR is one of the fundamental determinants
of HRV [28]. A positive relationship between RRI
and its variation has been shown to be closer in
patients with advanced HF [28]. This explains why
Copie et al. [29] found increased HR itself an inde-
pendent predictor of cardiac mortality, the sensi-
tivity, specificity and positive predictive value be-
ing practically the same as those of the triangular
index. We observed a closer correlation between
any HRV index and HR also in the setting of AF.
The unique property of the HRV fraction results
from calculation of a sum from any two boxes with
the greatest number of counts, while the interval
(side) of each box is the same, irrespective of R-R
544
Cardiology Journal 2011, Vol. 18, No. 5
www.cardiologyjournal.org
interval length. Therefore, the probability of find-
ing the highest number of counts is greater for box-
es lying in the region of short RRI on the scatter-
plot and so the probability is greater at faster HR.
In this way, the HRV fraction combines both HR
and its variability. A more detailed explanation of
the HRV fraction rationale has been described else-
where [18].
As indicated in our results, low values of stan-
dard time-domain measures were found in AF pa-
tients with depressed LVEF, who also had shorter
mean RRI. But mean values of these indices were
still higher than in SR-patients with preserved
LVEF. At the same time, the HRV fraction values
were lower in AF patients with abnormal LVEF, as
well as in SR patients with compromised LVEF.
This was in part due to a faster HR in patients with
LV dysfunction. The distribution of RRI was there-
fore more compact, and most RRI lay within two
boxes, from which the numbers had been used in
the HRV fraction calculation. Therefore, the distri-
bution of the remaining RRI has a smaller influence
on HRV fraction measurement, but it significantly
affects the calculation of the standard indices.
A reduced HRV in patients with low LVEF and
AF should be expected, since similar or even great-
er neurohormonal derangements were evidenced
in studies which compared levels of catecholamines
and several biologically active peptides in patients
with AF and SR [30, 31]. These humoral factors
mainly affect long-wave HR oscillations, which are
usually assessed by the indices of global 24-hour
HRV. The same factors could influence long-term
spectral components, which were found to be indis-
tinguishable in patients with AF or SR in a study by
Hayano et al. [32]. The HRV fraction allows simple
evaluation of the dynamics of the regulatory process
underlying the long-term HRV component, which may
be common, irrespective of cardiac rhythm.
A reduced HRV has been shown to carry a worse
prognosis in studies performed separately in SR
patients and AF patients with HF [5]. Thus, it might
be expected that similar results would be obtained
if a single, theoretically-derived index was used.
HRV fraction seems to be a good candidate, allow-
ing HRV evaluation in a combined population of pa-
tients with SR and AF simultaneously.
It should be noted that HRV fraction (and oth-
er HRV measures) accounted for somewhat differ-
ent features of ventricular rate in the presence of
SR and in AF. Accordingly, while SR is preserved,
the HRV fraction provides information similar to
standard global HRV measures that in fact reflect
mainly parasympathetic cardiac control at the level
of sinus node. However, in the presence of AF,
when parasympathetic cardiac control at the level
of atrio-venticular node predominates, ventricular
rate irregularity must not reflect autonomic nervous
control of the sinus node.
Conclusions
Our study has evaluated a simple and easily
understood index of HRV that permits assessment
of HRV irrespective of cardiac rhythm. The index
shows a similar dependence of heart rate variation
on LV function in patients with SR or AF. Its use-
fulness requires further studies to validate its pro-
spective role in risk stratification in a  population
of cardiac patients.
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